WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS

C07A BETA BLOCKING AGENTS

All plain beta blocking agents are classified in this group. Combination packages containing two different products (e.g. sotalol tablets and aspirin tablets in a combination package) are also classified in this group.

Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.


The DDDs are based on the treatment of mild-moderate hypertension.

The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.

C07B BETA BLOCKING AGENTS AND THIAZIDES

This group comprises combinations of beta blocking agents and thiazides. Different thiazides may occur at each 5th level.

Combinations of beta blocking agents, thiazides and other agents are classified at separate 5th levels using the 50-series.

See comments to C02L concerning the principles for assignment of DDDs for the combined preparations.

C07C BETA BLOCKING AGENTS AND OTHER DIURETICS

This group comprises combinations of beta blocking agents and diuretics excl. thiazides. Different diuretics except thiazides, may occur at each 5th level.

Combinations with other agents in addition, are classified at separate 5th levels using the 50-series.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS

This group comprises combinations of beta blocking agents, thiazides and other diuretics. Different thiazides and diuretics may occur at each 5th level.
Combinations with other agents in addition, are classified at separate 5th levels using the 50-series.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C07E BETA BLOCKING AGENTS AND VASODILATORS

This group comprises beta blocking agents and vasodilators (excl. calcium channel blockers) in combination.

Combinations with calcium channel blockers are classified in C07F.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES

This group comprises combinations of beta blocking agents and antihypertensives. Different antihypertensives may occur at each 5th level.

Beta blocking agents in combination with calcium channel blockers are classified in this group.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

Last updated: 2013-12-19